The "Quarterly R&I Literature Review" provides a brief summary of a selection of recent publications on R&I economics and policy. The aim of the Review is to inform policymakers on the latest findings from the literature that links R&I economics to R&I policy. The Literature Review, together...

Since 1984, the European Union (EU) invests in research and innovation (R&I) through the EU Framework Programmes (FP). This study sheds light on the added value of these long-term investments. To do so, the paper reviews the historical evolution of the FPs, presents the economic rationales for...

This paper provides a rationale on why investing in research and innovation (R&I) matters for Europe. It describes the potential of R&I to strengthen EU's competitiveness, support a green and sustainable future, and build a fair European society. EU's R&I performance is presented, of which the...

Using new and unique survey evidence on digitalisation activities and investment in climate change of non-financial firms in the EU and the US, this article documents the trend towards twin digital and green investment in the corporate landscape after the COVID-19 pandemic. We use information...

The EU is challenged by a persistent leadership gap in the global health innovation landscape, with the US leading in corporate health innovation and venture capital (VC) funding. The EU health innovation landscape is more concentrated in older "incumbent leading firms," while the US has a more...

The necessity to meet climate and environmental targets, while at the same time ensuring economic and social sustainability,requires a transformation that will generate enough benefits to compensate the losers.